Commentary: Effect of fecal microbiota transplantation on non-alcoholic fatty liver disease: A randomized clinical trial
- PMID: 36439219
- PMCID: PMC9685304
- DOI: 10.3389/fcimb.2022.1056394
Commentary: Effect of fecal microbiota transplantation on non-alcoholic fatty liver disease: A randomized clinical trial
Keywords: diet therapy long-term efficacy; exercise therapy; fecal microbiota transplantation (FMT); gut microbiota; lifestyle interventions; non-alcoholic fatty liver disease (NAFLD).
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
-
Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial.Front Cell Infect Microbiol. 2022 Jul 4;12:759306. doi: 10.3389/fcimb.2022.759306. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35860380 Free PMC article. Clinical Trial.
References
-
- Boursier J., Mueller O., Barret M., Machado M., Fizanne L., Araujo-Perez F., et al. . (2016). The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology. 63, 764–775. doi: 10.1002/hep.28356 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical